Literature DB >> 12131999

Low access to a highly effective therapy: a challenge for international tuberculosis control.

Christopher Dye1, Catherine J Watt, Daniel Bleed.   

Abstract

OBJECTIVE: To determine the scale of the tuberculosis (TB) problem facing the international Stop TB Partnership by measuring the gap between present rates of case detection and treatment success, and the global targets (70% and 85%, respectively) to be reached by 2005 under the WHO DOTS strategy.
METHODS: We analysed case notifications submitted annually to WHO from up to 202 (of 210) countries and territories between 1980 and 2000, and the results of treatment for patients registered between 1994 and 1999.
FINDINGS: Many of the 148 national DOTS programmes in existence by the end of 2000 have shown that they can achieve high treatment success rates, close to or exceeding the target of 85%. However, we estimate that only 27% of all the new smear-positive cases that arose in 2000 were notified under DOTS, and only 19% were successfully treated. The increment in case-finding has been steady at about 133 000 additional smear-positive cases in each year since 1994. In the interval 1999- 2000, more than half of the extra cases notified under DOTS were in Ethiopia, India, Myanmar, the Philippines, and South Africa.
CONCLUSION: With the current rate of progress in DOTS expansion, the target of 70% case detection will not be reached until 2013. To reach this target by 2005, DOTS programmes must find an additional 333 000 cases each year. The challenge now is to show that DOTS expansion in the major endemic countries can significantly accelerate case finding while maintaining high cure rates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131999      PMCID: PMC2567525     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

2.  Contribution of rural-to-urban migration in the prevalence of drug resistant tuberculosis in China.

Authors:  W Wang; J Wang; Q Zhao; N D Darling; M Yu; B Zhou; B Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-21       Impact factor: 3.267

Review 3.  Should interventions to reduce respirable pollutants be linked to tuberculosis control programmes?

Authors:  Enis Baris; Majid Ezzati
Journal:  BMJ       Date:  2004-11-06

Review 4.  HIV and tuberculosis coinfection: inextricably linked liaison.

Authors:  Vincent Idemyor
Journal:  J Natl Med Assoc       Date:  2007-12       Impact factor: 1.798

5.  Tuberculosis vaccines: current progress.

Authors:  Ian M Orme
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Does tuberculosis have a seasonal pattern among migrant population entering Iran?

Authors:  Mahmood Moosazadeh; Narges Khanjani; Abbas Bahrampour; Mahshid Nasehi
Journal:  Int J Health Policy Manag       Date:  2014-05-03

7.  Expanding tuberculosis case detection by screening household contacts.

Authors:  Mercedes C Becerra; Iliana F Pachao-Torreblanca; Jaime Bayona; Rosa Celi; Sonya S Shin; Jim Yong Kim; Paul E Farmer; Megan Murray
Journal:  Public Health Rep       Date:  2005 May-Jun       Impact factor: 2.792

8.  Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.

Authors:  Marcus B Conde; Anne Efron; Carla Loredo; Gilvan R Muzy De Souza; Nadja P Graça; Michelle C Cezar; Malathi Ram; Mohammad A Chaudhary; William R Bishai; Afranio L Kritski; Richard E Chaisson
Journal:  Lancet       Date:  2009-04-04       Impact factor: 79.321

Review 9.  Global tuberculosis control: lessons learnt and future prospects.

Authors:  Christian Lienhardt; Philippe Glaziou; Mukund Uplekar; Knut Lönnroth; Haileyesus Getahun; Mario Raviglione
Journal:  Nat Rev Microbiol       Date:  2012-05-14       Impact factor: 60.633

Review 10.  Cough Due to TB and Other Chronic Infections: CHEST Guideline and Expert Panel Report.

Authors:  Stephen K Field; Patricio Escalante; Dina A Fisher; Belinda Ireland; Richard S Irwin
Journal:  Chest       Date:  2017-11-28       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.